Jenifer H. Voeks

Jenifer H. Voeks

Auto-generated profile, based on publicly available information

Jenifer H. Voeks

Department of Neurology, Medical University of South Carolina, Charlottesville

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2017 in International Journal of Stroke
Verified
Journal Article
Closed access
PDF file
VHVirginia J Howard
Virginia J Howard
JMJames F Meschia
James F Meschia
BLBrajesh K Lal
Brajesh K Lal
TTTanya N Turan
Tanya N Turan
GRGary S Roubin
Gary S Roubin
TBThomas G Brott
Thomas G Brott
Rationale: Trials conducted decades ago demonstrated that carotid endarterectomy by skilled surgeons reduced stroke risk in asymptomatic patients. Developments in carotid stenting and improvements in medical prevention of stroke caused by atherothrombotic disease challenge understanding of the benefits of revascularization. Aim: Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2) will test whether carotid endarterectomy or carotid stenting plus contemporary intensive medical therapy is superior to intensive medical therapy alone in the primary prevention of stroke in patients with high-grade asymptomatic carotid stenosis. Methods and design: CREST-2 is two multicenter randomized trials of revascularization plus intensive medical therapy versus intensive medical therapy alone. One trial randomizes patients to carotid endarterectomy plus intensive medical therapy versus intensive medical therapy alone; the other, to carotid stenting plus intensive medical therapy versus intensive medical therapy alone. The risk factor targets of centrally directed intensive medical therapy are LDL cholesterol <70 mg/dl and systolic blood pressure <140 mmHg. Study outcomes: The primary outcome is the composite of stroke and death within 44 days following randomization and stroke ipsilateral to the target vessel thereafter, up to four years. Change in cognition and differences in major and minor stroke are secondary outcomes. Sample size: Enrollment of 1240 patients in each trial provides 85% power to detect a treatment difference if the event rate in the intensive medical therapy alone arm is 4.8% higher or 2.8% lower than an anticipated 3.6% rate in the revascularization arm. Discussion: Management of asymptomatic carotid stenosis requires contemporary randomized trials to address whether carotid endarterectomy or carotid stenting plus intensive medical therapy is superior in preventing stroke beyond intensive medical therapy alone. Whether carotid endarterectomy or carotid stenting has favorable effects on cognition will also be tested. Trial registration: United States National Institutes of Health Clinicaltrials.gov NCT02089217

5 September 2014 in Current Hypertension Reports
Verified
Journal Article
Closed access
PDF file
DLDaniel T. Lackland
Daniel T. Lackland
JVJenifer H. Voeks
Jenifer H. Voeks

14 June 2015 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
OGOrlando M. Gutiérrez
Orlando M. Gutiérrez
SJSuzanne Judd
Suzanne Judd
JVJenifer H. Voeks
Jenifer H. Voeks
ACApril P. Carson
April P. Carson
MSMonika M. Safford
Monika M. Safford
HWHenry E. Wang
Henry E. Wang
Sepsis is the syndrome of body-wide inflammation triggered by infection and is a major public health problem. Diet plays a vital role in immune health but its association with sepsis in humans is unclear. We examined 21,404 participants with available dietary data from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study, a national cohort of 30,239 black and white adults ≥45 years of age living in the US. The primary exposures of interest were five empirically derived diet patterns identified via factor analysis within REGARDS participants: “Convenience” (Chinese and Mexican foods, pasta, pizza, other mixed dishes), “Plant-based” (fruits, vegetables), “Southern” (added fats, fried foods, organ meats, sugar-sweetened beverages), “Sweets/Fats” (sugary foods) and “Alcohol/Salads” (alcohol, green-leafy vegetables, salad dressing). The main outcome of interest was investigator-adjudicated first hospitalized sepsis events. A total of 970 first sepsis events were observed over ~6 years of follow-up. In unadjusted analyses, greater adherence to Sweets/Fats and Southern patterns was associated with higher cumulative incidence of sepsis, whereas greater adherence to the Plant-based pattern was associated with lower incidence. After adjustment for sociodemographic, lifestyle and clinical factors, greater adherence to the Southern pattern remained associated with higher risk of sepsis (hazard ratio [HR] comparing the fourth to first quartile, HR 1.39, 95 % CI 1.11,1.73). Race modified the association of the Southern diet pattern with sepsis (Pinteraction = 0.01), with the Southern pattern being associated with modestly higher adjusted risk of sepsis in black as compared to white participants (HR comparing fourth vs. first quartile HR 1.42, 95 % CI 0.75,2.67 vs. 1.21, 95 % CI 0.93,1.57, respectively). A Southern pattern of eating was associated with higher risk of sepsis, particularly among black participants. Determining reasons for these findings may help to devise strategies to reduce sepsis risk.

14 March 2018 in Trials
Verified
Journal Article
Open access
PDF file
FSFred S. Sarfo
Fred S. Sarfo
OSOsei Sarfo-Kantanka
Osei Sarfo-Kantanka
SASheila Adamu
Sheila Adamu
VOVida Obese
Vida Obese
JVJennifer Voeks
Jennifer Voeks
BOBruce Ovbiagele
Bruce Ovbiagele
There is an unprecedented rise in the prevalence of stroke in sub-Saharan Africa (SSA). Secondary prevention guidelines recommend that antihypertensive, statin and antiplatelet therapy be initiated promptly after ischemic stroke and adhered to in a persistent fashion to achieve optimal vascular-risk reduction. However, these goals are seldom realized in routine clinical care settings in SSA due to logistical challenges. We seek to assess whether a polypill containing fixed doses of three antihypertensive agents, a statin and antiplatelet therapy taken once daily per os for 12 months among recent stroke survivors would result in carotid intimal thickness regression compared with usual care (UC). The Stroke Minimization through Additive Anti-atherosclerotic Agents in Routine Treatment (SMAART) trial is a phase 2, open-label, evaluator-blinded trial involving 120 Ghanaian recent-ischemic-stroke survivors. Using a computer-generated sequence, patients will be randomly allocated 1:1 into either the intervention arm or UC. Patients in the intervention arm will receive Polycap DS® (containing aspirin, 100 mg; atenolol, 50 mg; ramipril, 5 mg; thiazide, 12.5 mg; simvastatin, 20 mg) taken as two capsules once daily. Patients in the UC will receive separate, individual secondary preventive medications prescribed at the physician’s discretion. Both groups will be followed for 12 months to assess changes in carotid intimal thickness regression – a surrogate marker of atherosclerosis – as primary outcome measure. Secondary outcome measures include adherence to therapy, safety and tolerability, health-related quality of life, patient satisfaction, functional status, depression and cognitive dysfunction. An efficacy-suggesting SMAART trial could inform the future design of a multi-center, double-blinded, placebo-controlled, parallel-group, randomized controlled trial comparing the clinical efficacy of the polypill strategy for vascular risk moderation among stroke survivors in SSA. ClinicalTrials.gov , ID: NCT03329599 . Registered on 11 February 2017.

22 October 2021 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
JMJon S. Matsumura
Jon S. Matsumura
BHBret M. Hanlon
Bret M. Hanlon
KRKenneth Rosenfield
Kenneth Rosenfield
JVJenifer H. Voeks
Jenifer H. Voeks
GHGeorge Howard
George Howard
TBThomas G. Brott
Thomas G. Brott

18 June 2021 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
WHWilliam Haley
William Haley
FSFayaz Shawl
Fayaz Shawl
WSW. Charles Sternbergh
W. Charles Sternbergh
TTTanya N. Turan
Tanya N. Turan
KBKevin Barrett
Kevin Barrett
JMJames F. Meschia
James F. Meschia